Cathie Wood picks up nearly 2 million shares of struggling, cheap stock
Cathie Wood's Ark Invest has been boosting its bets in biotechnology lately, one of several disruptive sectors that Ark grants investors exposure to. Ark's…
Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cathie Wood's Ark Invest has been boosting its bets in biotechnology lately, one of several disruptive sectors that Ark grants investors exposure to. Ark's…
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares rose 5.8% during mid-day trading on Tuesday . The stock traded as high as $6.92 and last traded at $6.91. Approximately 2,910,226 shares changed hands during mid-day trading, a decline of 13% from the average daily volume of 3,335,453 shares. The stock had previously closed at […]
Scaling up means having more power to bring to bear on core activities.
It's time to get constructive on mid-cap tech stocks, according to Karen Kharmandarian, senior portfolio manager at Thematics Asset Management.
The popular growth investor keeps adding to some of her favorite stocks.